These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19137216)

  • 21. Concept of REACH and impact on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jan; 27(1):5-21. PubMed ID: 18480145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Principles of establishing the registries of chemical substances in the United States and Europe].
    Krajewski J; Ruta U; Wasiela T
    Med Pr; 1992; 43(1):81-6. PubMed ID: 1635448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the proposed REACH regulation.
    Petry T; Knowles R; Meads R
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):24-32. PubMed ID: 16249048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olefins and chemical regulation in Europe: REACH.
    Penman M; Banton M; Erler S; Moore N; Semmler K
    Chem Biol Interact; 2015 Nov; 241():59-65. PubMed ID: 25861726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. REACH and reproductive and developmental toxicology: still questions.
    Scialli AR; Guikema AJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):63-9. PubMed ID: 22239083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hazard and risk assessment of teratogenic chemicals under REACH.
    Prutner W
    Methods Mol Biol; 2013; 947():517-43. PubMed ID: 23138924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory assessment of chemicals within OECD member countries, EU and in Russia.
    Fjodorova N; Novich M; Vrachko M; Kharchevnikova N; Zholdakova Z; Sinitsyna O; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(1):40-88. PubMed ID: 18322867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The German REACH Congress 2016: a workshop report.
    Reihlen A; Jepsen D; Broschinski L; Luch A; Schulte A
    Arch Toxicol; 2018 Mar; 92(3):1343-1347. PubMed ID: 29453549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.
    Moermond CT; Janssen MP; de Knecht JA; Montforts MH; Peijnenburg WJ; Zweers PG; Sijm DT
    Integr Environ Assess Manag; 2012 Apr; 8(2):359-71. PubMed ID: 22006646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Priority setting in the REACH system.
    Hansson SO; Rudén C
    Toxicol Sci; 2006 Apr; 90(2):304-8. PubMed ID: 16340010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental exposure scenarios: development, challenges and possible solutions.
    Ahrens A; Traas TP
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S7-15. PubMed ID: 18000528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of REACH on classification for human health hazards.
    Oltmanns J; Bunke D; Jenseit W; Heidorn C
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):474-81. PubMed ID: 25128672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Workshop: use of "read-across" for chemical safety assessment under REACH.
    Patlewicz G; Roberts DW; Aptula A; Blackburn K; Hubesch B
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):226-8. PubMed ID: 23266660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The implementation of REACH: initial perspectives from government, industry, and civil society.
    Cohen AK
    Int J Occup Environ Health; 2011; 17(1):57-62. PubMed ID: 21344820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
    Tynkkynen S; Santonen T; Stockmann-Juvala H
    Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulating chemicals: law, science, and the unbearable burdens of regulation.
    Silbergeld EK; Mandrioli D; Cranor CF
    Annu Rev Public Health; 2015 Mar; 36():175-91. PubMed ID: 25785889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification & Labelling Inventory: role of ECHA and notification requirements.
    Schöning G
    Ann Ist Super Sanita; 2011; 47(2):140-5. PubMed ID: 21709382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generic exposure scenarios: their development, application, and interpretation under REACH.
    Money C; Margary A; Noij D; Hommes K
    Ann Occup Hyg; 2011 Jun; 55(5):451-64. PubMed ID: 21551289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory decision-making under uncertainty: are costs proportionate to benefits when restricting dangerous chemicals on European markets?
    Brouwer R; Cauchi J; Verhoeven J
    Regul Toxicol Pharmacol; 2014 Apr; 68(3):438-46. PubMed ID: 24518386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.